BDBM419311 4-{[5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl]methyl}-N-{2-[3-(but-3-yn-1-yl)-3H-diaziren-3-yl]ethyl}-1,2,5-oxadiazole-3-carboxamide::US10457686, Example 2

SMILES CC(C)(C)c1nc(N2CCC(F)(F)C2)c2nn(Cc3nonc3C(=O)NCCC3(CCC#C)N=N3)nc2n1

InChI Key InChIKey=VARZACRRKDTJHC-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419311   

TargetCannabinoid receptor 2(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM419311(4-{[5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2...)
Affinity DataKi:  932nMAssay Description:The affinity of the compounds of the invention for cannabinoid receptors was determined using recommended amounts of membrane preparations (PerkinElm...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2020
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM419311(4-{[5-tert-Butyl-7-(3,3-difluoropyrrolidin-1-yl)-2...)
Affinity DataKi: >1.00E+4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2020
Entry Details
US Patent